Movement Disorders
Feature
New report highlights gaps in knowledge on marijuana use
Evidence review shows when using cannabis or cannabinoids is effective, ineffective, or harmful.
Feature
Gene therapy to boost levodopa conversion enzyme shows benefit in Parkinson’s
Patients with advanced Parkinson’s disease were able to reduce daily levodopa doses in phase Ib testing of an experimental gene therapy from...
Conference Coverage
Recognizing anti-NMDA receptor encephalitis psychosis on the psych ward
VIENNA – Early treatment of this serious autoimmune disorder is effective and rewarding.
Conference Coverage
Gait predicts cognitive decline in early Parkinson’s
Key clinical point: Gait characteristics, not cognition, predict cognitive decline in early Parkinson’s. Major finding: Gait pace, variability,...
Conference Coverage
Anxiety, depression may precede Parkinson’s by 25 years
Key clinical point: Patients can have clinical anxiety and/or depression for 25 years or more before being diagnosed with Parkinson’s disease....
Conference Coverage
Experts offer tips on anxiety, depression, and psychosis in Parkinson’s
Key clinical point: A cross-sectional study uncovered a statistically significant link between anxiety and psychosis in Parkinson’s disease. Major...
News
No evidence to show Alzheimer’s or Parkinson’s transmission via blood transfusion
An exhaustive retrospective cohort study shows no data to support the hypothesis that Alzheimer’s or Parkinson’s diseases can be transmitted...
News
FDA approves first drug to treat hallucinations in Parkinson’s psychosis
News
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
News
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
Commentary
Prion-like transmission of neurodegenerative pathology stirs concern
Recent developments regarding the nature of transmissible pathologic proteins in a variety of common neurodegenerative diseases – including...